Optibiotix Health (OPTI)

 

OPTI Share PerformanceMore

52 week high83.00 19/05/17
52 week low49.60 23/04/18
52 week change -10.77 (-14.80%)
4 week volume4,561,362 31/03/18
price61.98
price date1524738603
close60.00

Media for (OPTI)

Latest NewsMore

OptiBiotix Health inks distribution pact with Cambridge Commodities

OptiBiotix Health said it had entered into a non-exclusive agreement with Cambridge Commodities to distribute its weight...

SlimBiome non-exclusive UK distribution agreement

RNS Number: 8380L OptiBiotix Health PLC 24 April 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Non-Exclusive UK distribution agreement for SlimBiome OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces it has entered into a non-exclusive distribution...

Appointment of Head of Online Sales and Marketing

RNS Number: 3750L OptiBiotix Health PLC 19 April 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") 19 April 2018 Appointment of Head of Online Sales and Marketing OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces the appointment of Steven Riley as He...

OptiBiotix Health forges Pakistan distribution agreement with Trigen

OptiBiotix Health, which develops treatments for obesity, high cholesterol, diabetes and skin care, said it had entered into a ...

CholBiome exclusive distribution agreement

RNS Number: 2211L OptiBiotix Health PLC 18 April 2018 18 April 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Exclusive distribution agreement with Trigen Pharma for CholBiome OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces it has entered into a fi...

OptiBiotix Health files three patents

OptiBiotix Health, a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, h...

New patent filings for SweetBiotix

RNS Number: 8495J OptiBiotix Health PLC 05 April 2018 O p ti B i o tix H eal th p l c ("O p t i Bi o t ix" o r t h e "C o m pan y") New patent filings: SweetBiotix OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, a nn o un ces three new patent filing...

Scientific and commerical update

RNS Number: 9723I OptiBiotix Health PLC 27 March 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Scientific and commercial update OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, provides the following scientific and commerci...

Fundamental DataMore

EPS-1.67
Dividend yield0 %

Latest discussion posts More

  • Proactive interview

    Very confident proactive interview. http://tinyurl.com/ybaj4rq2
    25-Apr-2018
    elrico63
  • Revenues building

    Much more to come with #5-6m retail partners, poss 3. More deals in the pipeline. c#12m revenues by 2019 with EXISTING partners. http://tinyurl.com/y8luwy8v
    25-Apr-2018
    elrico63
  • Radio 4 series the Second Genome - link

    Sorry forgot to paste link - https://www.bbc.co.uk/programmes/b09zgykv/episodes/player
    24-Apr-2018
    ambience

Users' HoldingsMore

Users who hold Optibiotix Health also hold..

Codes & Symbols

ISINGB00BP0RTP38
SymbolsOPTI, LSE:OPTI, OPTI.L, OPTI:LN, LON:OPTI, XLON:OPTI